Calcium/phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis. (updated: March 4, 2015)
The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.
No sequence conservation computed yet.
This protein is annotated as membranous in Gene Ontology.
Total structural coverage: 71%
(right-click above to access to more options from the contextual menu)
The reference OMIM entry for this protein is 186360
Annexin a7; anxa7
Annexin vii; anx7
Synexin; snx
DESCRIPTION
Synexin is a calcium-dependent membrane-binding protein that not only fuses membranes but also acts as a voltage-dependent calcium channel.
CLONING
Burns et al. (1989) isolated and sequenced a set of overlapping cDNA clones for human synexin. Its derived amino acid sequence shows strong homology in the C-terminal domain with a previously identified class of calcium-dependent membrane-binding proteins, including endonexin II (
131230), lipocortin I (
151690), calpactin I heavy chain (
114085), and others. Magendzo et al. (1991) cloned 3 variants of synexin cDNA from a human fibroblast cDNA library. Sequence analysis indicated that the variants were formed by alternative splicing and use of alternate polyadenylation signals. Northern blot analysis of fibroblasts revealed transcripts of 2.0 and 2.4 kb. Using primers designed to differentiate between these 2 forms by PCR, Magendzo et al. (1991) found the larger transcript, containing a 66-bp exon, in human and monkey brain, heart, and skeletal muscle. They found the variant lacking this exon in liver, lung, kidney, spleen, fibroblasts, and placenta. Western blot analysis indicated the presence of the larger protein in human skeletal muscle and the smaller protein in lung.
GENE FUNCTION
The ANX7 gene is located on chromosome 10q21, a site long hypothesized to harbor a tumor suppressor gene or genes associated with prostate and other cancers. To test this hypothesis, Srivastava et al. (2001) analyzed the action of the ANX7 gene on colony formation by human tumor cell lines. They also examined the expression of the ANX7 protein in a large number of prostate cancers using tumor tissue microarray technology. Finally, they tested a panel of primary and metastatic prostate cancers for evidence of loss of heterozygosity (LOH). They found that human tumor cell proliferation and colony formation were markedly reduced when the wildtype ANX7 gene was transfected into 2 prostate tumor cell lines. Consistently, analysis of ANX7 protein expression in human prostate tumor microarrays revealed a significantly higher rate of loss of ANX7 expression in metastatic and local recurrences of hormone refractory prostate cancer as compared with primary tumors (P = 0.0001). Using 4 microsatellite markers at or near the ANX7 locus and laser capture microdissected tumor cells, 35% of 20 primary prostate tumors showed LOH. The microsatellite marker closest to the ANX7 locus showed the highest rate of LOH, including 1 homozygous deletion. Srivastava et al. (2001) concluded that the ANX7 gene exhibits many biologic and genetic properties expected of a tumor suppressor gene and may play a role in prostate cancer progression. Caohuy et al. (1996) present experimental evidence, based on studies of recombinant human ANXA7 and isolated bovine chromaffin cells, that ANXA7 is a Ca(2+)-dependent GTP binding protein. ANXA7 was active in a chromaffin granule aggregation assays in the presence of Ca(2+) and GTP, and was deactivated upon GTP hydrolysis.
GENE STRUCTURE
Shirvan et al. (1994) determined that the synexin gene contains 14 exons, including an alternatively spliced cassette exon, and spans approximately 34 kb of DNA. Only 5 of the 14 spliced exons are conserved compared to other annexins; the differences are particularly pronounced in the exons that encode the C-terminal third and fourth conserved repeats in the gene product. Shirvan et al. (1994) concluded that the ANXA ...
More on the omim web site
Subscribe to this protein entry history
Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated
Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated
Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated
June 20, 2017: Protein entry updated
Automatic update: comparative model was added.
March 16, 2016: Protein entry updated
Automatic update: OMIM entry 186360 was added.
Feb. 24, 2016: Protein entry updated
Automatic update: model status changed